The pharmaceutical sector has issued a strident, urgent plea to the Health Department. They are imploring officials to immediately reconsider the newly gazetted 1.4% SEP increase in the maximum Single Exit Price (SEP) for medicines in 2026. The adjustment, set at a mere 1.47%, is a significant blow to the industry. They had anticipated an increase more than double that…